122 related articles for article (PubMed ID: 2907350)
21. Relative DA1-dopamine-receptor agonist and alpha-adrenoceptor antagonist activity of fenoldopam in the anesthetized dog.
Kohli JD; Glock D; Goldberg LI
J Cardiovasc Pharmacol; 1988 Jan; 11(1):123-6. PubMed ID: 2450250
[TBL] [Abstract][Full Text] [Related]
22. Ganglionic dopamine receptors as mediators of the inhibition of neurogenic vasoconstriction produced by fenoldopam.
Lokhandwala MF; Sabouni MH
J Auton Pharmacol; 1985 Dec; 5(4):301-5. PubMed ID: 2869042
[TBL] [Abstract][Full Text] [Related]
23. Dopamine receptors and hypertension. Physiologic and pharmacologic implications.
Goldberg LI
Am J Med; 1984 Oct; 77(4A):37-44. PubMed ID: 6148892
[TBL] [Abstract][Full Text] [Related]
24. Cardiovascular and renal profile of acute peripheral dopamine1-receptor agonism with fenoldopam.
Glück Z; Jossen L; Weidmann P; Gnädinger MP; Peheim E
Hypertension; 1987 Jul; 10(1):43-54. PubMed ID: 2885268
[TBL] [Abstract][Full Text] [Related]
25. Increase in plasma renin activity evoked by fenoldopam in dogs is directly mediated by dopamine1 receptor stimulation.
Montier F; Katchadourian P; Pratz J; Cavero I
J Cardiovasc Pharmacol; 1989 May; 13(5):739-47. PubMed ID: 2472522
[TBL] [Abstract][Full Text] [Related]
26. Effects of selective dopamine receptor subtype agonists on cardiac contractility and regional haemodynamics in rats.
Polakowski JS; Segreti JA; Cox BF; Hsieh GC; Kolasa T; Moreland RB; Brioni JD
Clin Exp Pharmacol Physiol; 2004 Dec; 31(12):837-41. PubMed ID: 15659045
[TBL] [Abstract][Full Text] [Related]
27. Hemodynamic effects of selective dopamine receptor agonists in the rat and dog.
Hieble JP; Owen DA; Harvey CA; Blumberg AL; Valocik RE; DeMarinis RM
Clin Exp Hypertens A; 1987; 9(5-6):889-912. PubMed ID: 2887313
[TBL] [Abstract][Full Text] [Related]
28. Systemic hemodynamic and regional blood flow effects of LY141865, a selective dopamine receptor agonist.
Hahn RA; MacDonald BR
J Pharmacol Exp Ther; 1984 Sep; 230(3):558-68. PubMed ID: 6470973
[TBL] [Abstract][Full Text] [Related]
29. Influence of fenoldopam and quinpirole in the guinea-pig stomach.
Guenaneche F; Schuurkes JA; Lefebvre RA
J Auton Pharmacol; 1991 Aug; 11(4):221-35. PubMed ID: 1682324
[TBL] [Abstract][Full Text] [Related]
30. Effects of selective D1 and D2 dopamine agonists on cockroach salivary gland acinar cells in vitro.
Evans AM; Green KL
Br J Pharmacol; 1991 Dec; 104(4):787-92. PubMed ID: 1687366
[TBL] [Abstract][Full Text] [Related]
31. The effects of quinpirole and fenoldopam on the potassium-evoked overflow of endogenous dopamine and noradrenaline in dog mesenteric arteries.
Soares-da-Silva P
Naunyn Schmiedebergs Arch Pharmacol; 1990; 341(1-2):37-42. PubMed ID: 1969118
[TBL] [Abstract][Full Text] [Related]
32. Dopaminergic and alpha-adrenergic control of neurotransmission in human right atrium.
Rump LC; Riera-Knorrenschild G; Schwertfeger E; Bohmann C; Spillner G; Schollmeyer P
J Cardiovasc Pharmacol; 1995 Sep; 26(3):462-70. PubMed ID: 8583789
[TBL] [Abstract][Full Text] [Related]
33. Evidence that specific dopamine-1 receptor activation is involved in dopamine-induced renin release.
Antonipillai I; Broers MI; Lang D
Hypertension; 1989 May; 13(5):463-8. PubMed ID: 2566577
[TBL] [Abstract][Full Text] [Related]
34. Different dopamine receptor subtypes mediate the neurogenic vasodilation produced by fenoldopam and SK & F 85174 in the dog hindlimb.
Lokhandwala MF; Watkins HO; Dlewati A
Eur J Pharmacol; 1987 Nov; 143(3):383-90. PubMed ID: 2891555
[TBL] [Abstract][Full Text] [Related]
35. Enhanced behavioral stereotypies elicited by intrastriatal injection D1 and D2 dopamine agonists in intact rats.
Bordi F; Meller E
Brain Res; 1989 Dec; 504(2):276-83. PubMed ID: 2574622
[TBL] [Abstract][Full Text] [Related]
36. Blunted pressor responsiveness to quinpirole, a specific dopamine D2 receptor agonist, in conscious deoxycorticosterone acetate/NaCl hypertensive rats is related to atrial natriuretic peptide release.
Chen YF; Jin HK; Paul R; Nagahama S
J Pharmacol Exp Ther; 1988 Aug; 246(2):485-92. PubMed ID: 2969976
[TBL] [Abstract][Full Text] [Related]
37. Effects of dopamine D1 and dopamine D2 receptor agonists on coronary and peripheral hemodynamics.
Zhao RR; Fennell WH; Abel FL
Eur J Pharmacol; 1990 Nov; 190(1-2):193-202. PubMed ID: 1981750
[TBL] [Abstract][Full Text] [Related]
38. Dopamine1 receptor agonist and alpha-2 adrenoceptor antagonist effects of fenoldopam in rabbits.
Szabo B; Hedler L; Starke K
J Pharmacol Exp Ther; 1986 Dec; 239(3):881-6. PubMed ID: 2879034
[TBL] [Abstract][Full Text] [Related]
39. Comparison of the effects of the novel inotropic agent, ibopamine, with epinine, dopamine and fenoldopam on renal vascular dopamine receptors in the anesthetized dog.
Nichols AJ; Smith JM; Shebuski RJ; Ruffolo RR
J Pharmacol Exp Ther; 1987 Aug; 242(2):573-8. PubMed ID: 2886644
[TBL] [Abstract][Full Text] [Related]
40. Absence of postsynaptic DA2 dopamine receptors in the dog renal vasculature.
Horn PT; Kohli JD
Eur J Pharmacol; 1991 May; 197(2-3):125-30. PubMed ID: 1680707
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
